Benitec Biopharma Inc (BNTC)
8.00
-1.25
(-13.51%)
USD |
NASDAQ |
May 13, 16:00
8.00
0.00 (0.00%)
After-Hours: 16:25
Benitec Biopharma Cash from Operations (TTM): -18.07M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -18.07M |
September 30, 2023 | -18.54M |
June 30, 2023 | -18.01M |
March 31, 2023 | -18.77M |
December 31, 2022 | -18.16M |
September 30, 2022 | -15.67M |
June 30, 2022 | -15.90M |
March 31, 2022 | -16.20M |
Date | Value |
---|---|
December 31, 2021 | -14.77M |
September 30, 2021 | -14.75M |
June 30, 2021 | -12.83M |
March 31, 2021 | -10.82M |
December 31, 2020 | -9.60M |
September 30, 2020 | -9.35M |
June 30, 2020 | -7.535M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-18.77M
Minimum
Mar 2023
-7.535M
Maximum
Jun 2020
-14.60M
Average
-15.67M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Galectin Therapeutics Inc | -32.96M |
TG Therapeutics Inc | 20.28M |
BioVie Inc | -41.11M |
Jaguar Health Inc | -33.24M |
First Wave BioPharma Inc | -12.38M |